Thermo Fisher Scientific (NYSE:TMO) shares moved lower in premarket trading, even after the company reported first-quarter results that exceeded analyst expectations on both earnings and revenue.
The company posted earnings per share of $5.44, above the consensus forecast of $5.25, while revenue increased 6% year-on-year to $11.01 billion, beating estimates of $10.87 billion.
Profit growth remains steady
Adjusted operating income rose 6% from the prior year to $2.40 billion, with the adjusted operating margin at 21.8%, broadly unchanged from 21.9% in the same quarter last year.
“We delivered a strong start to the year, reflecting excellent execution by our team, as we leveraged the PPI Business System to drive operational excellence and enable our customers’ success,” said Marc Casper, chairman and CEO.
“Looking ahead, we are well-positioned to deliver a strong year. As the trusted partner to our customers, we are uniquely equipped to help them accelerate their innovation and enhance their productivity,” he added.
Updated outlook expected
Thermo Fisher said it will provide updated financial guidance for 2026 during its earnings conference call scheduled for 8:30 a.m. Eastern Time.